Skip to main content
BIOTECH logo

BIOTECH — Investor Relations & Filings

Ticker · BST ISIN · ES0184980003 LEI · 959800GNYT6ZZEWPEW29 BME Growth Professional, scientific and technical activities
Open in API
Filings indexed 2,317 across all filing types
Latest filing 2025-03-19 Net Asset Value
Country ES Spain
Listing BME Growth BST

About BIOTECH

https://asebio.com/en/members/directory…

Biotechnology Assets Biat Group is a biotechnology corporate group with a global commercial structure operating through several subsidiaries. Its subsidiary Biobide is a provider of preclinical services, specializing in tailor-made toxicity and efficacy testing using the zebrafish (ZF) animal model. ZIP Solutions develops and promotes a proprietary set of inteins for high-value industrial applications, including gene therapy, immunotherapy, in-vitro diagnostics, smart vaccines (RNA & DNA), and affinity-based protein purification. The Bionatur division manages biotech assets for human and animal health. The group focuses on licensing its platforms and products, conducting preclinical research, and improving recombinant and DNA vaccines through collaborations.

Recent filings

Filing Released Lang Actions
Net Asset Value(s)
Net Asset Value Classification · 99% confidence The document explicitly contains the heading 'Net Asset Value(s)' and presents a table detailing 'Net Asset Value' and 'NAV/per Share' for a specific fund ('First Trust NYSE Arca Biotechnology UCITS ETF') as of a specific date ('18.03.2025'). This directly matches the definition for Net Asset Value updates, which corresponds to the filing code NAV.
2025-03-19 English
Net Asset Value(s)
Net Asset Value Classification · 99% confidence The document explicitly contains the heading 'Net Asset Value(s)' and presents a table detailing 'Net Asset Value' and 'NAV/per Share' for a specific fund (First Trust NYSE Arca Biotechnology UCITS ETF) as of a specific date (17.03.2025). This directly matches the definition for Net Asset Value updates, which corresponds to the filing code NAV.
2025-03-18 English
Net Asset Value(s)
Net Asset Value Classification · 99% confidence The document explicitly contains the heading 'Net Asset Value(s)' and presents a table detailing 'Net Asset Value' and 'NAV/per Share' for a specific fund (First Trust NYSE Arca Biotechnology UCITS ETF) as of a specific date (14.03.2025). This directly matches the definition for Net Asset Value updates, which corresponds to the filing code NAV.
2025-03-17 English
Net Asset Value(s)
Net Asset Value Classification · 99% confidence The document explicitly contains the heading 'Net Asset Value(s)' and presents a table detailing 'Net Asset Value' and 'NAV/per Share' for a specific fund on a specific date (13.03.2025). This directly matches the definition for Net Asset Value updates, which corresponds to the filing code NAV.
2025-03-14 English
Net Asset Value(s)
Net Asset Value Classification · 99% confidence The document explicitly contains the heading 'Net Asset Value(s)' and presents a table detailing 'Net Asset Value' and 'NAV/per Share' for a specific fund ('First Trust NYSE Arca Biotechnology UCITS ETF') as of a specific date ('12.03.2025'). This directly matches the definition for Net Asset Value updates, which corresponds to the filing code NAV.
2025-03-13 English
Net Asset Value(s)
Net Asset Value Classification · 99% confidence The document explicitly contains the heading 'Net Asset Value(s)' and presents a table detailing 'Net Asset Value' and 'NAV/per Share' for a specific fund ('First Trust NYSE Arca Biotechnology UCITS ETF') as of a specific date (11.03.2025). This directly matches the definition for Net Asset Value updates, which corresponds to the filing code NAV.
2025-03-12 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.